Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics Daniel SavittJoseph Jankovic Leading Article 13 April 2019 Pages: 797 - 810
Drugs in Development for Acute Kidney Injury Matthew HulseMitchell H. Rosner Leading Article 19 April 2019 Pages: 811 - 821
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer Sally C. M. LauUllas BatraHerbert H. Loong Review Article 08 May 2019 Pages: 823 - 831
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents Lydia L. BenitezPeggy L. Carver Review Article 15 May 2019 Pages: 833 - 853
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients? Aurelie LengletNicolas FabresseZiad A. Massy Original Research Article 06 May 2019 Pages: 855 - 862
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy Yvette N. LambEmma D. Deeks Adis Drug Evaluation 16 May 2019 Pages: 863 - 874
Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis Lesley J. Scott Adis Drug Evaluation 16 May 2019 Pages: 875 - 886
Peficitinib: First Global Approval Anthony MarkhamSusan J. Keam AdisInsight Report 15 May 2019 Pages: 887 - 891
Risankizumab: First Global Approval Kate McKeageSean Duggan AdisInsight Report 17 May 2019 Pages: 893 - 900
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia Young-A. HeoYahiya Y. SyedSusan J. Keam Correction Open access 17 May 2019 Pages: 901 - 901